TARO-GLICLAZIDE MR: may contain the presence of pink coloured stain (identified as Candesartan Cilexetil)
· Published by Health Canada · Official notice
Alert type: Health product recall
Category: Health products - Drugs
Product: TARO-GLICLAZIDE MR
Issue: Health products - Product safety
What to do: Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Audience: General public, Healthcare, Industry
Recall class: Type II
We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.
Get health product recall alertsCA$3.99/mo · cancel anytime
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|
| TARO-GLICLAZIDE MR | TARO-GLICLAZIDE MR | DIN 02439328 | Tablet (Extended-Release) | GLICLAZIDE 60 MG | PTF5132A |
Affected lot may contain the presence of pink coloured stain (identified as Candesartan Cilexetil).